--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About VNDA20260220C10
Pharmaceutical
Vanda Pharmaceuticals Inc., was incorporated in Delaware in 2002. The company is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. The company strives to advance new approaches to bring important new drugs to market through responsible innovation. The company is committed to using technologies that support sound science, including genetics and genomics, in drug discovery, clinical trials and commercial positioning of products.
